Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization

被引：33

作者：

Chiu, JH ^{[1
]}

Topol, EJ ^{[1
]}

Whitlow, PL ^{[1
]}

Hsu, AP ^{[1
]}

Tuzcu, EM ^{[1
]}

Franco, I ^{[1
]}

Moliterno, DJ ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 92卷 / 05期

关键词：

D O I：

10.1016/S0002-9149(03)00726-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The association between peripheral vascular disease and outcomes after percutaneous coronary intervention was examined in the Do Tirofiban and Reopro Give Similar Efficacy Outcome Trial (TARGET). After adjustments in a multivariate model, a history of peripheral vascular disease was found to be associated with a two- to threefold increase in mortality at 1 year after coronary stent placement. (C) 2003 by Excerpta Medica, Inc.

引用

页码：582 / 583

页数：2

共 9 条

[1] THE PREVALENCE OF PERIPHERAL ARTERIAL-DISEASE IN A DEFINED POPULATION [J].

CRIQUI, MH ;

FRONEK, A ;

BARRETTCONNOR, E ;

KLAUBER, MR ;

GABRIEL, S ;

GOODMAN, D .

CIRCULATION, 1985, 71 (03) :510-515

[2] MORTALITY OVER A PERIOD OF 10 YEARS IN PATIENTS WITH PERIPHERAL ARTERIAL-DISEASE [J].

CRIQUI, MH ;

LANGER, RD ;

FRONEK, A ;

FEIGELSON, HS ;

KLAUBER, MR ;

MCCANN, TJ ;

BROWNER, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (06) :381-386

[3] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J].

Gent, M ;

Beaumont, D ;

Blanchard, J ;

Bousser, MG ;

Coffman, J ;

Easton, JD ;

Hampton, JR ;

Harker, LA ;

Janzon, L ;

Kusmierek, JJE ;

Panak, E ;

Roberts, RS ;

Shannon, JS ;

Sicurella, J ;

Tognoni, G ;

Topol, EJ ;

Verstraete, M ;

Warlow, C .

LANCET, 1996, 348 (9038) :1329-1339

[4] A direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation and stent placement: Rationale and design of the TARGET study [J].

Moliterno, DJ ;

Topol, EJ .

AMERICAN HEART JOURNAL, 2000, 140 (05) :722-726

[5] Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study [J].

Moliterno, DJ ;

Yakubov, SJ ;

DiBattiste, PM ;

Herrmann, HC ;

Stone, GW ;

Macaya, C ;

Neumann, FJ ;

Ardissino, D ;

Bassand, JP ;

Borzi, L ;

Yeung, AC ;

Harris, KA ;

Demopoulos, LA ;

Topol, EJ .

LANCET, 2002, 360 (9330) :355-360

[6] Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease [J].

Papamichael, CM ;

Lekakis, JP ;

Stamatelopoulos, KS ;

Papaioannou, TG ;

Alevizaki, MK ;

Cimponeriu, AT ;

Kanakakis, JE ;

Papapanagiotou, A ;

Kalofoutis, AT ;

Stamatelopoulos, SF .

AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (06) :615-618

[7] Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. [J].

Topol, EJ ;

Moliterno, DJ ;

Herrmann, HC ;

Powers, ER ;

Grines, CL ;

Cohen, DJ ;

Cohen, EA ;

Bertrand, M ;

Neumann, FJ ;

Stone, GW ;

DiBattiste, PM ;

Demopoulos, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1888-1894

[8] THE RELATIONSHIP BETWEEN ANKLE BRACHIAL INDEX, OTHER ATHEROSCLEROTIC DISEASE, DIABETES, SMOKING AND MORTALITY IN OLDER MEN AND WOMEN [J].

VOGT, MT ;

MCKENNA, M ;

WOLFSON, SK ;

KULLER, LH .

ATHEROSCLEROSIS, 1993, 101 (02) :191-202

[9] DECREASED ANKLE ARM BLOOD-PRESSURE INDEX AND MORTALITY IN ELDERLY WOMEN [J].

VOGT, MT ;

CAULEY, JA ;

NEWMAN, AB ;

KULLER, LH ;

HULLEY, SB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (04) :465-469

← 1 →